Article
Pan-active imidazolopiperazine antimalarials target the <i>Plasmodium falciparum</i> intracellular secretory pathway
2019-08-15
Abstract excerpt
<h4> A bstract </h4> One of the most promising new compound classes in clinical development for the treatment of malaria is the imidazolopiperazines (IZPs) class. Human trials have demonstrated that members of the IZP series, which includes KAF156 (Ganaplacide) and GNF179, are potent and effective against Plasmodium symptomatic asexual blood-stage infections. Unlike other commonly used antimalarials, they also...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- db971877-5839-5a4e-8b98-2c3c548852ac
- DOI
- 10.1101/735894
